Search results
Eli Lilly and Company (NYSE:LLY) Major Shareholder Lilly Endowment Inc Sells 22,206 Shares of Stock
ETF DAILY NEWS· 7 hours agoEli Lilly and Company (NYSE:LLY – Get Free Report) major shareholder Lilly Endowment Inc sold 22,206 shares of the business’s stock in ...
Diabetes drug recommended to treat obesity on the NHS
Press Association News via AOL· 2 minutes agoThe type 2 diabetes drug Mounjaro has been recommended to help obese people lose weight on the NHS....
Barclays bullish on Eli Lilly stock with positive outlook By Investing.com
Investing.com· 1 day agoOn Monday, Barclays expressed a positive stance on Eli Lilly (NYSE:LLY) stock, maintaining an...
Lilly Endowment sells over $18 million in Eli Lilly stock By Investing.com
Investing.com· 15 hours agoLilly Endowment Inc., a major shareholder in Eli Lilly & Co (NYSE:LLY), has recently sold a significant portion of its holdings in the ...
Eli Lilly Beefs Up Neuro Pipeline With Addition Of Preclinical ALS, Dementia Prospect
Benzinga via Yahoo Finance· 15 hours agoOn Monday, privately held QurAlis Corporation entered into an exclusive license agreement with Eli ...
Eli Lilly executive sells over $600k in company stock By Investing.com
Investing.com· 15 hours agoEli Lilly & Co (NYSE:LLY) executive Donald A. Zakrowski, who serves as the Senior Vice President of...
Is Eli Lilly Stock A Buy On A Recent Crohn's Disease-Related Rally?
Investor's Business Daily· 5 days agoEli Lilly stock rocketed and broke out earlier this month after unveiling promising results for its...
Eli Lilly and Company Lima Stock Price Today | NYSE LLY Live Ticker - Investing.com
Investing.com· 5 hours agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for ...
Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030,...
Business Insider via Yahoo Finance· 2 days agoZepbound is Eli Lilly's new weight-loss drug.Brendan McDermid/Reuters The anti-obesity drug market...
This Is the Biggest Risk for Eli Lilly and Novo Nordisk Investors | The Motley Fool
The Motley Fool· 3 days agoEli Lilly (LLY 0.65%) and Novo Nordisk (NVO 1.87%) are the two most valuable healthcare companies in...